Q1 Results: New Revenue Record

Print Friendly

11th Straight Quarter of Sequential Revenue Growth

BioLife announced financial results for the first quarter ending March 31, 2013 on May 14th. Revenue set a new quarterly record, besting the previous record of $2.1 million set in Q4 2012. Q1 revenue of $2.2 million was aided by an unusually large contribution in the amount of $609k from licensing. Revenue increased 158% yoy and 6% sequentially. This now marks the 11th consecutive quarter of sequential revenue growth. BLFS was also cash flow positive (ex-changes in working capital) in Q1.
Entire report: Zacks May 16, 2013.

Team BioLife Hits the Course at Bothell’s Can Do 5K/10K

Print Friendly
Mike Rice, CEO (right) with BioLife team members:  Maile Blair, Sandy Jones, Stacy Holk (Team Captain), Emily Bome, and families.

Mike Rice, CEO (right) with BioLife team members: Maile Blair, Sandy Jones, Stacy Holk (Team Captain), Emily Bome, and families.

CANDO13_dcc_1BioLife Solutions is once again, a proud sponsor of Bothell’s Can Do 5K/10K which benefits Northwest Special Families, an organization dedicated to helping families of children with special needs. Northwest Special Families is part of the Center for Human Services and also partners with the Northshore YMCA to create inclusive and adaptive programming for local area youth.

This year’s event took place on April 27th, under partly sunny skies. It is the third consecutive year that BioLife Solutions has participated in this important community event.

Biopreservation Considerations During Hair Transplantation

Print Friendly
ajm_art Aby J. Mathew. A review of cellular biopreservation considerations during hair transplantation. Hair Transplant Forum International, 2013; 23(1):1-11.

BioLife Recognized as Science and Technology Education Supporter in YouTube Video

Print Friendly

Even with BioLife Solutions’ growing global recognition, we also value connecting with our community on a local level. Mike Rice, CEO and Aby J. Mathew, Senior Vice President and Chief Technology Officer, recently attended the Northshore Schools Foundation’s (NSF) annual luncheon where BioLife was recognized as a Major Sponsor in 2012, supporting the Foundation’s STEM programs (Science, Technology, Engineering and Math). NSF partners with local Bothell area schools, parent groups, and businesses to enhance learning opportunities for Northshore students, supporting education for STEM-related careers in order to fill the ever-growing skills gap in high tech industries.

See YouTube presentation:
(If video does not appear please view here: Skills Gap Northshore Schools Foundation).

As a local biotechnology industry partner, BioLife participated in Woodinville High School’s BIO EXPO Symposium where students had the opportunity to investigate careers in biotechnology and develop projects related to the industry. Michael Weaver, Product Development Manager for BioLife, helped judge at this event, while Dr. Aby J. Mathew served as an onsite industry expert. In addition, Dr. Mathew recently addressed the topic of Stem Cells & Regenerative Medicine – The Facts and The Future Potential with a group of Bothell area middle school students at the Environmental Adventure School (EAS).

BioLife is honored to be recognized as a supporter of STEM education and plans to continue to partner with our community to promote science and technology education.

BioLife Solutions Unveils New Exhibit

Print Friendly

BioLife unveils new booth at ISCT meeting in Seattle

BioLife Solutions plans a global trade show presence in 2013 beginning with  Phacilitate’s Cell & Gene Forum in Washington DC, January 28-30. A new exhibit was recently created to illustrate how BioLife’s clinical grade, serum-free, protein- free, cGMP biopreservation media is used in more than 50 customer clinical trials “head-to-toe”. The booth exhibit was unveiled at ISCT’s 2012 Annual Meeting in Seattle (pictured) and will travel to ISCT’s 2013 meeting in Auckland, New Zealand, April 22-25.

For more information regarding BioLife’s upcoming conference schedule, please continue to check our Events page.

 

Ileal Carcinoids and CryoStor®

Print Friendly

Tobias Hofving. CD133 and ALDH1 as Prospective Markers for Cancer Stem Cells in Ileal Carcinoids

T Cells and CryoStor®

Print Friendly

Wang, Xiuli; Naranjo, Araceli; Brown, Christine E.; Bautista, Cherrilyn; Wong, ChingLam W.; Chang, Wen-Chung; Aguilar, Brenda; Ostberg, Julie R.; Riddell, Stanley R.; Forman, Stephen J.; Jensen, Michael C. Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8+ Central Memory T Cells Manufactured at Clinical Scale. Journal of Immunotherapy: November–December 2012; Volume 35, Issue 9, p 689–701, doi: 10.1097/CJI.0b013e318270dec7.

Bioartificial Kidney and CryoStor®

Print Friendly

Deborah A. Buffington, Christopher J. Pino, Lijun Chen, Angela J. Westover, Gretchen Hageman, and H. David Humes. Bioartificial Renal Epithelial Cell System (BRECS): A Compact, Cryopreservable Extracorporeal Renal Replacement Device. Cell Medicine, Vol. 4, pp. 33–43, 2012 2155-1790/12 $90.00. Printed in the USA. All rights reserved. DOI: http://dx.doi.org/10.3727/215517912X653328.

Human IPS Cells and CryoStor®

Print Friendly

Jin S, Yao H, Weber JL, Melkoumian ZK, Ye K. A Synthetic, Xeno-Free Peptide Surface for Expansion and Directed Differentiation of Human Induced Pluripotent Stem Cells. PLoS ONE 7(11): e50880. doi:10.1371/journal.pone.0050880. (November 2012)

Urine Stem Cells and CryoStor®

Print Friendly

Ting Zhou, Christina Benda, Sarah Dunzinger, Yinghua Huang, Jenny Cy Ho, Jiayin Yang, Yu Wang, Ya Zhang, Qiang Zhuang, Yanhua Li, Xichen Bao, Hung-Fat Tse, Johannes Grillari, Regina Grillari-Voglauer, Duanqing Pei1 and Miguel A Esteban. Generation of human induced pluripotent stem cells from urine samples. Nature Protocols, 2012; Vol 7, No. 12, 280-289. Published online 8 November 2012; doi:10.1038/nprot.2012.115